• All Things Urticaria podcast episode 71: The patient perspective

    Professor Marcus Maurer is joined by the president of Global Allergy & Airways Patient Platform (GAAPP), Tonya Winders, for a special Urticaria Day (UDAY) episode to discuss the role patient advocacy groups play in supporting individuals with chronic spontaneous urticaria. Both experts explore patient unmet needs and highlight methods clinicians can use to help overcome these barriers.

    Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

    Utilise the following external link to access additional resources relating to the topics discussed in this episode: Global Allergy & Airways Patient Platform.

    Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!

    For more information about the UCARE/ACARE network and its activities, please visit: UCARE WebsiteUCARE LevelUp ProgramACARE WebsiteUCARE 4U WebsiteUDAY WebsiteCRUSE Control App and CURE Registry

  • All Things Urticaria Podcast Episode 68: Angioedema and CSU

    Dr Régis de Albuquerque Campos joins Professor Marcus Maurer to discuss the implications of angioedema and its impact on people living with chronic spontaneous urticaria (CSU). Dr Campos highlights diverse aspects of the burden of CSU and the impact misdiagnosis has on quality of life. Professor Maurer provides an overview of the current treatment landscape, differential diagnosis, unmet needs in angioedema clinical trials and the utilisation of omalizumab in managing angioedema associated with CSU.

    Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

    For more information about the UCARE/ACARE network and its activities please visit: UCARE WebsiteUCARE LevelUp ProgramACARE WebsiteUCARE 4U WebsiteUDAY WebsiteCRUSE Control App and CURE Registry.

     

  • All Things Urticaria Podcast Episode 67: Angioedema and artificial intelligence

    Professor Markus Magerl joins Professor Marcus Maurer in this episode to explore the significance of differential diagnosis in the identification of angioedema in chronic spontaneous urticaria (CSU). Professor Magerl takes a deep dive into the prospective use of artificial intelligence (AI) in the analysis of data derived from a questionnaire utilising algorithmic models. Both professors, Maurer and Magerl, discuss the implications AI can have in enhancing the diagnostic accuracy of angioedema.

    Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

    For more information about the UCARE/ACARE network and its activities please visit: UCARE WebsiteUCARE LevelUp ProgramACARE WebsiteUCARE 4U WebsiteUDAY WebsiteCRUSE Control App and CURE Registry.

     

  • All Things Urticaria Podcast Episode 66: Urticaria and the CRUSE app

    Professor Marcus Maurer is joined by Dr Aistė Ramanauskaitė to explore the CRUSE app’s potential advantages for individuals suffering from chronic spontaneous urticaria. Professor Maurer emphasises the importance and utilisation of the CRUSE app, while Dr. Ramanauskaitė delves into the various benefits and practical applications offered by the app.

    Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

    Utilise the following external link to access additional resources relating to the topics discussed in this episode: UCARE YouTube Channel.

  • All Things Urticaria Podcast Episode 65: Audience proposed question: Guidance for potential treatments of CSU

    Professor Martin Metz joins Professor Marcus Maurer to answer an audience proposed question focusing on what will guide physicians in the recommendations for individual patients to identify the most beneficial treatment option to treat chronic spontaneous and inducible urticaria. Both experts delve into the current treatment options available, and exciting treatments that are currently in clinical trials.

    Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

    Utilise the following external links to access additional resources relating to the topics discussed in this episode: Dupilumab in CSURemibrutinib in CSUBruton’s tyrosine kinase inhibition—An emerging therapeutic strategy in immune-mediated dermatological conditionsAn open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticariaBarzolvolimab in mast cell depletionChronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advancesChronic urticaria and the pathogenic role of mast cells and Urticaria (an overview).

  • All Things Urticaria Podcast Episode 64: A general practitioner’s perspective

    Professor Marcus Maurer is joined by GP Dr Dermot Ryan to discuss the role of GPs in the diagnosis and management of chronic urticaria. Professor Maurer and Dr Ryan highlight the positive impact that physicians have in limiting patient distress while increasing patient confidence, despite the time-limited interactions. They also explore the impact of mistreatment on a patient’s life.

    Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

    Utilise the following external links to access additional resources relating to the topics discussed in this episode:

    The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria and Clinical review: The suggested management pathway for urticaria in primary care

  • All Things Urticaria Podcast Episode 63: Soluble IgE Receptor in Urticaria

    Professor Marcus Maurer asks Dr Sherezade Moñino-Romero about her research into soluble IgE receptor and its potential as a marker of treatment response in chronic urticaria. They also discuss the art of communicating science to the public and why it is so vital to do it effectively.

    Do you have suggestions for future episodes?  Please reach out to us via  email or fill out this form here and offer your suggestions for future topics and expert selection!

  • All Things Urticaria Podcast Episode 62: The role of angioedema in the treatment of CSU

    Professor Marcus Maurer is accompanied by Professor Marc Riedl to delve into the symptomatology and pathophysiology of angioedema in chronic spontaneous urticaria (CSU). The mechanistic aetiology of angioedema within the context of CSU pathology is also explored. Professor Marc Riedl examines therapeutic treatments for patients concurrently experiencing angioedema in CSU while exploring how the characterisation of autoimmune and auto allergic pathophysiological mechanisms can impact treatment decisions. Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
    Do you have suggestions for future episodes?  Please reach out to us via  email or fill out this form here and offer your suggestions for future topics and expert selection!
  • All Things Urticaria Podcast Episode 61: Bruton’s tyrosine kinase inhibitors in the treatment of CSU

    Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinical efficacy, advantages, and impact on patient quality of life of utilising Bruton’s tyrosine kinase inhibitors for the treatment of CSU, along with further discussion of alternative treatments. Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
    Do you have suggestions for future episodes?  Please reach out to us via  email or fill out this form here and offer your suggestions for future topics and expert selection!
  • All Things Urticaria Podcast Episode 60: Updates from AAAAI Conference 2023

    We are proud to present the 6th episode of our successful All Things Urticaria Podcst Series

    In this episode, Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.

    Do you have suggestions for future episodes? Please reach out to us via  email or fill out this form here and offer your suggestions for future topics and expert selection!